Prospective registration program / central review of morphologic diagnosis / follow-up study / genomic research for aplastic anemia and myelodysplastic syndromes.

Not Applicable

Recruiting

• Conditions: Aplastic anemia (AA) Myelodysplastic syndromes (MDS)

• Registration Number: JPRN-UMIN000043704
• Lead Sponsor: Ministry of Health, Labor and Welfare (MHLW)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-04-01
• Last Update Posted: 17 October 2023
• Study Completion: 2041-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Not provided

Exclusion Criteria

The case without documented consensus is excluded.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The assessment including cellularity of bone marrow, presence and frequency of dysplasia, evaluation of other notable morphological findings, and morphologic diagnosis by central review. The evaluation of clinical outcomes under current treatment practice in Japan and of therapeutic efficacy by prospective registration program.